Skip to main content

HSAG ESRD Alerts, Recalls, and Notices

Patient with Doctor Inside Hospital with Busy Nurses
Top

 

  • FDA MedWatch: Recall - Oral Liquid Docusate Sodium

    Saturday, July 16, 2016

    The FDA is alerting healthcare professionals that PharmaTech LLC, Davie, Florida, is voluntarily recalling all non-expired lots of Diocto Liquid, a docusate sodium solution distributed by Rugby Laboratories, Livonia, Michigan. The agency confirmed the product has been contaminated with Burkholderia cepacia, a bacteria linked to an outbreak in five states. 

    Read More
  • FDA MedWatch: July 2016 Safety Labeling Changes

    Thursday, July 14, 2016

    The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections.

    Read More
  • FDA MedWatch: INRatio and INRatio2 PT/INR Monitor System by Alere: Recall

    Tuesday, July 12, 2016

    Alere Inc. will be initiating a voluntary withdrawal of the Alere INRatio and INRatio2 PT/INR Monitoring System.

    Read More
  • Zika Updates

    Monday, June 20, 2016

    The following information has been added to or recently updated on the CDC Zika and CDC Travelers' Health sites.

    Read More
  • Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars

    Thursday, June 2, 2016

    FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches. Since marketing of the Zecuity patch began in September 2015, a large number of patients have reported they experienced burns or scars on the skin where the patch was worn.

    Read More